SC 13G/A: Arbutus Biopharma Corp
Ticker: ABUS · Form: SC 13G/A · Filed: 2024-02-14T00:00:00.000Z
Sentiment: neutral
Topics: sc-13g-a
AI Summary
SC 13G/A filing by Arbutus Biopharma Corp.
Risk Assessment
Risk Level: low
From the Filing
0001013594-24-000200.txt : 20240214 0001013594-24-000200.hdr.sgml : 20240214 20240214163859 ACCESSION NUMBER: 0001013594-24-000200 CONFORMED SUBMISSION TYPE: SC 13G/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20240214 DATE AS OF CHANGE: 20240214 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: Arbutus Biopharma Corp CENTRAL INDEX KEY: 0001447028 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 980597776 STATE OF INCORPORATION: A1 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-85963 FILM NUMBER: 24639448 BUSINESS ADDRESS: STREET 1: 701 VETERANS CIRCLE CITY: WARMINSTER STATE: PA ZIP: 18974 BUSINESS PHONE: 604-419-3200 MAIL ADDRESS: STREET 1: 701 VETERANS CIRCLE CITY: WARMINSTER STATE: PA ZIP: 18974 FORMER COMPANY: FORMER CONFORMED NAME: TEKMIRA PHARMACEUTICALS Corp DATE OF NAME CHANGE: 20110607 FORMER COMPANY: FORMER CONFORMED NAME: TEKMIRA PHARMACEUTICALS CORP DATE OF NAME CHANGE: 20081003 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: Whitefort Capital Management, LP CENTRAL INDEX KEY: 0001884931 ORGANIZATION NAME: IRS NUMBER: 820808818 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A BUSINESS ADDRESS: STREET 1: 12 E. 49TH STREET STREET 2: 40TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10017 BUSINESS PHONE: 2122594370 MAIL ADDRESS: STREET 1: 12 E. 49TH STREET STREET 2: 40TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10017 SC 13G/A 1 arbutus13ga1-02142024.htm SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C.  20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1 )* Arbutus Biopharma Corporation (Name of Issuer) Common Shares, without par value (Title of Class of Securities) 03879J100 (CUSIP Number) December 31, 2023 (Date of Event which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [ ]              Rule 13d-1(b) [x]              Rule 13d-1(c) [ ]              Rule 13d-1(d) *The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page. The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the   Notes ). 1. NAMES OF REPORTING PERSONS       Whitefort Capital Management, LP     2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP       (a)    [ ]   (b)    [ ]     3. SEC USE ONLY     4. CITIZENSHIP OR PLACE OF ORGANIZATION       Delaware     NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH:     5. SOLE VOTING POWER       0     6. SHARED VOTING POWER       13,197,062     7. SOLE DISPOSITIVE POWER       0     8. SHARED DISPOSITIVE POWER       13,197,062     9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON       13,197,062     10. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)   [ ]     11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)       7.9%     12. TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)       PN, IA